MANAGEMENT DISCUSSION AND ANALYSIS REPORT Industry Structure & Development The Indian Pharmaceutical Industry currently tops the charts amongst India’s science based industries with wide ranging capabilities in the complex field of drug manufacture & technology. With Leading MNC players from around the world accounting for potential takeover of Indian Companies and Indian Pharma Sector is growing very healthy along with economy. A highly organized sector, the Indian pharmaceutical industry is estimated to be worth $6billion, growing about 8 to 9% annually against the GDP projection of 6%. It ranks very high amongst all the third world countries. The pharma industry in India meets around 70% of the country’s demand for bulk drugs, drug intermediaries, pharma formulations, tablets, capusules, orals and injectibles. There are approximately 250 large units which form the core of the pharma industry in India. About the Company During the year ended the company has filed Capital Reduction petition with Honb'le High Court at Hyderabad and the petition is in final stage of hearing. Once the Carry Forward Losses are written off the management is confident of restarting operations of the company. Your company has started a new corporate office in Hyderabad and is in process of negotiating manufacturing some very vital Pharma Indigents that will have an assured buy back arrangement with couple of leading Pharmaceuticals manufacturers. Your company has already paid advance for identifying suitable land to put up a state of Art plant in coming near future. Management of company is working very hard to add to share holder's value. Opportunities & Threats Indian Pharma Sector is one of the sunrises Sector. With the new government initiative of MAKE in INDIA there is significant new opportunity in the Indian Pharma Industry. With many MNC's acquiring small and midsize Pharma companies. Your company foresees a better future in years to come. The company is also trying to identify suitable land parcel where in company can start its further activities. Advances for the same have already been given and the process to negotiate and finalize should be completed once the Capital Reduction process is over. Outlook The management is trying to bring back company on the growth trajectory and revive its operations there by significantly adding to share holder's value. By the order of the board For Shiva Medicare Limited Sd/- Amit Jain (Director) Place: Hyderabad Date: 18.08.2015 |